Vacuole formation and cytokeratin rearrangement of hepatoma cells induced by teleocidin are not associated with down-regulation of protein kinase C.
PLC/PRF/5 human hepatoma cells cultured with teleocidin reduced the rate of cell proliferation and were transformed into large cells with many vacuole-like subcellular structures. In these vacuolated cells, the protein content per cell increased without changing the total cellular protein synthesis. Cytokeratin was one of the proteins which increased quantitatively. This intermediate filament formed fibrous network structures throughout the enlarged cytoplasm. The assembly of other cytoskeletal proteins such as actin, tubulin, and vimentin was not altered remarkably, suggesting that teleocidin morphologically transformed the hepatoma cells by changing the assembly of cytokeratin protein selectively. On the other hand, the alterations of cell proliferation, cell morphology, and cytokeratin assembly induced by teleocidin were not associated with either down-regulation of protein kinase C or reduced number of epidermal growth factor receptors. In addition, these teleocidin effects were not mimicked by the protein kinase C agonist 1-oleoyl-2-acetylglycerol or inhibited by the protein kinase C inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine. From these results it can be speculated that the morphological transformation and reduced cell proliferation induced by teleocidin may be mediated by still unknown mechanisms unrelated to protein kinase C.
Kaneko
Y
Y
First Department of Medicine, University of Tokyo, Faculty of Medicine, Japan.
Tsukamoto
A
A
Kurokawa
K
K
D006528:Carcinoma, Hepatocellular; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002462:Cell Membrane / Q000201:enzymology; D003598:Cytoskeletal Proteins / Q000302:isolation & purification / Q000378:metabolism* / Q000648:ultrastructure; D003600:Cytosol / Q000201:enzymology; D004273:DNA, Neoplasm / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007633:Keratins / Q000378:metabolism* / Q000648:ultrastructure; D007700:Kinetics; D008113:Liver Neoplasms; D008235:Lyngbya Toxins / Q000494:pharmacology*; D008970:Molecular Weight; D009363:Neoplasm Proteins / Q000378:metabolism; D009687:Nuclear Proteins / Q000302:isolation & purification / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism*; D014617:Vacuoles / Q000187:drug effects / Q000648:ultrastructure*
D003598:Cytoskeletal Proteins; D004273:DNA, Neoplasm; D008235:Lyngbya Toxins; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; C022176:teleocidins; D007633:Keratins; D011493:Protein Kinase C